Orange Book product · Brand (NDA)
ZYDELIG
IDELALISIB
At a glance
Jul 23, 2014
Approved
Brand (NDA)
Application
AB
TE code
4
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 23, 2014
12 yr 1 mo ago
Today
Patent 9492449 expires
Listed method-of-use patent (U-1914) expiration.
Mar 11, 2030
in 3 yr 9 mo
Patent 10730879 expires
Listed drug substance patent expiration.
Mar 05, 2033
in 6 yr 10 mo
Patent 8865730 expires
Listed drug substance patent expiration.
Mar 05, 2033
in 6 yr 10 mo
Patent 9469643 expires
Listed drug substance patent expiration.
Sep 02, 2033
in 7 yr 4 mo
Pharmaceutical detail
Active ingredient
IDELALISIB
Strength
100MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 205858
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (4)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9492449 | Mar 11, 2030 | in 3 yr 9 mo | U-1914 |
| 10730879 | Mar 05, 2033 | in 6 yr 10 mo | SubstanceProduct |
| 8865730 | Mar 05, 2033 | in 6 yr 10 mo | SubstanceProductU-1615 |
| 9469643 | Sep 02, 2033 | in 7 yr 4 mo | Substance |
